Creative Artists Agency Names Steve Hasker CEO of CAA Global
Leading entertainment and sports agency, Creative Artists Agency (CAA), announced today that industry veteran Steve Hasker has been appointed CEO of the recently structured CAA Global. He will manage the intersection between CAA's market-leading representation business and its high-growth businesses and investments, bringing together the agency's growth platforms and ongoing strategic initiatives. He will also join CAA's board of directors, and oversee the company's strategic planning, mergers and acquisitions, principal investing, and corporate development initiatives, as well as the company's data strategy.
Hasker most recently served as Global President and Chief Operating Officer of Nielsen Holdings PLC, where he oversaw all of Nielsen’s commercial, data, and product-related activities for both the media and consumer businesses. He joins CAA in January, 2018.
“CAA Global is an exciting step in the continued growth and diversification of CAA,” said agency President Richard Lovett. “Steve is a transformational and highly accomplished industry executive, and we are thrilled, after conducting an extensive search, to have found someone who also shares so profoundly our cultural priority of collaborative success. Under Steve’s leadership, we are confident that CAA Global will capitalize on the strength of CAA’s position at the nexus of talent, content, technology, and brands across the global marketplace to accelerate growth and innovation for CAA and our clients.”
CAA Global includes assets such as CAA China, a joint venture with CMC Capital Partners that builds upon CAA’s 12 years of success in the fast-growing market; Evolution Media, CAA’s merchant bank, founded in 2008, that has advised on billions of dollars in mergers and acquisitions and manages a $500 million media, technology and consumer brand investment vehicle; CAA Ventures, an early-stage venture capital fund with 45 portfolio companies; and Vancouver-based Creative Labs, which builds consumer-facing technology companies and next-generation media and entertainment experiences.
“CAA is very well positioned to take advantage of massive technology disruption and changing consumer behavior,” said Hasker. “I look forward to building upon CAA’s long history of industry leadership and relentless innovation to create successful new global businesses and opportunities for its clients and the company.”
CAA has long been recognized for its unmatched roster of the world’s premier artists, athletes, and blue-chip brands, as well as its category leadership in packaging television and film content and live experiences. CAA was also the first agency to build a sports business, create an investment bank, launch a venture fund, found technology start-up companies, establish a presence in China, and start a successful private equity vehicle, among other industry advances.
“CAA’s management team has demonstrated its ability to help drive the evolution of the media and entertainment industry. Since our initial investment in CAA, the company has continued to expand and diversify to capture its enormous potential,” said James Coulter, co-founder of global investment firm TPG, CAA’s majority shareholder. “CAA Global exemplifies these successful efforts, and with Steve as its CEO, we have a deeply experienced business leader with a proven ability to drive growth. We’re confident CAA will continue to accomplish exciting things.”
Prior to joining Nielsen in 2009, Hasker served as a partner in McKinsey & Company’s Global Media, Entertainment and Information practice, focused on strategy, growth, and innovation in television, data, filmed entertainment, sports, and digital advertising. Before joining McKinsey, Hasker served in a number of financial roles in the U.S., Russia and Australia.
A lecturer at Columbia University and New York University, Hasker’s research has been published in the Harvard Business Review. He graduated from the University of Melbourne and earned his MBA and Masters in International Affairs, both with honors, from Columbia University.
About Creative Artists Agency
Leading entertainment and sports agency Creative Artists Agency (CAA) represents many of the most successful professionals working in film, television, music, theatre, video games, sports, and digital content, and provides a range of strategic marketing and consulting services to corporate clients. CAA is a leader in sports, representing more than 1,000 of the world’s top athletes in football, baseball, basketball, hockey, soccer, tennis, and golf, and works in the areas of broadcast rights, corporate marketing initiatives, licensing, and sports properties for sales and sponsorship opportunities.
Creative Artists Agency (CAA)
Beth McClinton, 424.288.2247
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha